BLLN 株価分析 — BILLIONTOONE, INC. CLASS A COMMON STOCK (Healthcare >> Diagnostics & Research)
BLLN に関するよくある質問
BLLNのPER(株価収益率)は?
BILLIONTOONE, INC. CLASS A COMMON STOCK(BLLN)は現在PER 252.24倍で取引されています。
BLLNのROE(自己資本利益率)は?
BILLIONTOONE, INC. CLASS A COMMON STOCKのROEは4.99%です。
BLLNの配当利回りは?
BILLIONTOONE, INC. CLASS A COMMON STOCKの配当利回りは0.00%です。
BLLNの品質スコア(Quality Score)は?
当社のAIはBLLNの総合財務品質を100点中46点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
BLLNは今が買い時ですか?
当社AIのタイミングスコアは100点中91点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
BLLNはどのセクターに属しますか?
BILLIONTOONE, INC. CLASS A COMMON STOCKはHealthcare >> Diagnostics & Researchセクターに分類されます(NASDAQ市場)
BLLN AI Analysis Summary
Our AI summary for BLLN: BILLIONTOONE, INC. CLASS A COMMON STOCK (NASDAQ), Healthcare >> Diagnostics & Research sector. The stock currently trades at a P/E of 252.24, ROE of 4.99%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 138.60
Price
-0.99
(-0.71%)
Day Change
|
|
|---|
BLLN, ファンダメンタルスコアはnot good ( ファンダメンタル = 46) but テクニカルスコアは ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/Eが高い。割高銘柄。
ROEが低い
ROEの伸びが低い
平均ROEが低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
51% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
3006
|
| Magic Formula Rank by ROE |
3006
|
| Magic Formula Rank by ROIC |
2691
|
| Price | 138.60 |
| PBV / Sector |
12.70 / -29.69
|
| Earning Per Share | 0.54 |
| PE / Sector |
252.24 / 48.18
|
| PEG or PE/Growth / Sector |
N/A / 1.64
|
| Average 1M Daily Value |
78.59 M
|
| Average 1W Daily Value |
78.38 M
|
| Timing Factors |
|
71% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
60% |
| 配当 |
|
8% |
| 登録情報 |
| Analyze Date | 2026-08-01 07:59:33 |
| Symbol | BLLN |
| Name | BILLIONTOONE, INC. CLASS A COMMON STOCK |
| Sector | Healthcare >> Diagnostics & Research |
| Market | NASDAQ |
| Listed Shares | 41.44 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 6,420.51 / 38,081.42 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1035 O?Brien Drive, Menlo Park, CA, United States, 94025
Phone: 650 460 2551
Website: https://www.billiontoone.com
Employees: 713
Description: BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a methylation-based assay that quantifies the amount of cancer at the single molecule level without requiring a tissue biopsy, enabling real-time monitoring of patient response to therapy with unprecedented precision. BillionToOne, Inc. was incorporated in 2016 and is headquartered in Menlo Park, California.
ME vs SECTOR Healthcare >> Diagnostics & Research
Click a bubble to view stock details · Bubble size represents market capitalization share
Google